SLPI, WFDC2, WFIKKN2, and WFDC1 consistently showed low expression across tumor types, whereas WFDC5, WFDC3, and WFIKKN1 displayed heterogeneous expression profiles. This evidence concerns the gene WFDC2 and neoplasm.